YKL-40 play an important role in neo-angiogenesis acting as a potent angiogenic factor: it stimulates tumour vascularisation and induces FAK-MAPK via up-regulation of VEGF receptor 2 in endothelial cells. The gene discussed is CHI3L1; the disease is neoplasm.